MedTrace Logo

A Clinical Study on the Effect of DHA & ARA Candy on the Cognitive Improvement in Preschool Children

NCT06532435 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-11-05

No results posted yet for this study

Summary

The goal of this interventional study is to evaluate the effectiveness of DHA (docosahexaenoic acid) \& ARA (arachidonic acid) Candy on the cognitive development of preschool children (2-6 years old). The main questions it aims to answer are:

\- Does DHA \& ARA Candy improve the cognitive ability in terms of Wechsler Intelligence Scale for Children 4th edition-Chinese version (WISC-IV-Chinese)?

Researchers will administer the WISC-IV-Chinese following the guidelines strictly and analyze the score to conclude whether the DHA \& ARA is effective to improve the cognitive ability of preschool childchildren.

Participants will eat 1-2 candy (each contains 100mg DHA and 100mg ARA) daily for 4 consecutive weeks and take the WISC-IV-Chinese test for three times according to the protocol.

Conditions

  • Cognitive Change

Interventions

DIETARY_SUPPLEMENT

DHA & ARA Candy

Parpicipants need to eat 1-2 candy daily, for 4 consective weeks

Sponsors & Collaborators

  • Shandong Sibote Biotechnology Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Charlie Zhang, MD · Raison Biotech Group

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
2 Years
Max Age
6 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-25
Primary Completion
2024-08-10
Completion
2024-08-10

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06532435 on ClinicalTrials.gov